| Literature DB >> 25084813 |
Jean-Pascal Fournier1, Brigitte Escourrou, Julie Dupouy, Michel Bismuth, Jordan Birebent, Rachel Simmons, Jean-Christophe Poutrain, Stéphane Oustric.
Abstract
BACKGROUND: Teaching of medication prescribing is a specific challenge in general practice curriculum. The aim of this study was to identify and rank the competencies required for prescribing medication for general practice residents in France.Entities:
Mesh:
Year: 2014 PMID: 25084813 PMCID: PMC4129426 DOI: 10.1186/1471-2296-15-139
Source DB: PubMed Journal: BMC Fam Pract ISSN: 1471-2296 Impact factor: 2.497
Characteristics of participants of the 4 meetings
| Profession | | |
| | General practitioner | 8 (25.8%) |
| | General practice resident | 8 (25.8%) |
| | Community pharmacist | 5 (16.1%) |
| | Pharmacologist | 5 (16.1%) |
| | Medical Officer of the Health Insurance System | 5 (16.1%) |
| Years since completing training (for all participants but general practice resident, n = 23) | ||
| | 0–10 | 3 (13.0%) |
| | 10-20 | 4 (16.6%) |
| | >20 | 16 (69.6%) |
| Year in general practice curriculum (for general practice resident, n = 8) | ||
| | 1st year | 3 (37.5%) |
| | 2nd year | 1 (12.5%) |
| | 3rd year | 4 (50.0%) |
| Gender | | |
| | Female | 18 (58.1%) |
| Age | | |
| | <30 | 7 (22.6%) |
| | 30-40 | 5 (16.1%) |
| | 40-50 | 6 (19.4%) |
| >50 | 13 (41.9%) | |
Medication prescribing-related competencies (grouped by domains) and ranks*
| | | | | | |
| Prescribe the doses and durations following the indication | - | 5 | 8 | 2 | |
| Know where to find validated information for medication prescription | 12 | 13 | 10 | 5 | |
| Identify adverse drug reactions | - | 8 | 11 | 10 | |
| Be critical with new medications | 3 | 4 | - | 17 | |
| Identify potential drug interactions | 5 | 3 | 8 | 12 | |
| Prescribe in international nonproprietary names | 6 | 22 | - | 6 | |
| Prescribe in compliance to marketing authorizations | 19 | 19 | - | 6 | |
| | | | | | |
| Write a legible and understandable prescription for the patient and the one who administers the medication | - | 1 | 1 | 2 | |
| Use two-part prescription forms for patients with chronic condition falling under | 18 | 5 | 8 | 3 | |
| Abide by the terms of use for specific prescriptions: secured forms, special-status medication‡ , restricted prescription, unreimbursed prescription | 21 | 5 | 6 | 3 | |
| Include mandatory information of the prescription: identification of prescriber, date, patient’s name, age, weight (for children) | 3 | 17 | 1 | - | |
| Know the costs associated with medication prescription: reimbursement rate and patient’s contribution | 23 | 20 | 21 | - | |
| | | | | | |
| Identify specific populations (paediatric, pregnant, breastfeeding, elderly, renal impaired) | 8 | - | 1 | 1 | |
| Regularly re-evaluate chronic medication prescriptions | 6 | 4 | 19 | 13 | |
| Prescribe non-pharmacological treatment (lifestyle habits, dietary changes, physical activity, reassuring advices) over medication | 1 | - | 18 | 19 | |
| Deprescribe | 11 | 10 | 19 | - | |
| Abstain from systematic medication prescription | 1 | 2 | 17 | - | |
| Unifies prescription from different sources | 7 | 10 | 7 | - | |
| Use medication prescription software | 22 | 21 | 13 | 20 | |
| | | | | | |
| | | | | | |
| Explain a lack of medication prescription to the patient | 8 | 13 | - | 18 | |
| Decline inappropriate medication request for prescription medication | 16 | - | 20 | 16 | |
| Explain to the patient his/her medication prescription | 8 | 12 | 5 | 8 | |
| Assess patient’s adherence | 13 | 13 | 16 | - | |
| Identify barriers to medication use | - | 13 | 4 | - | |
| Assess self-medication | 16 | 8 | 14 | 15 | |
| Explain potential adverse drug reactions to the patient | - | 18 | 14 | 9 | |
| | | | | | |
| Being critical about the information supplied by the pharmaceutical industry | 15 | - | 22 | 11 | |
| Prescribe in collaboration with other health professionals: physicians, pharmacists, pharmacovigilance centres, Health Insurance System representatives, nurses, midwives | 13 | 23 | 23 | 13 | |
| Report adverse drug events to Pharmacovigilance Centre | 20 | - | 12 | 20 |
*Items with the lowest ranks were the most highly valued.
† Affection de Longue Durée: in France, a list of 30 serious chronic conditions (=Affection de Longue Durée) allows 100% reimbursement for health care related to these conditions. Specific two-part prescription forms are needed to identify which medications are related to the ALD (upper part of the form) and should be 100% reimbursed to the patient.
‡ Special-status medications include highly expensive medications, reimbursed only in very restrictive indications, in accordance with a fixed ‘special status medication list’. A specific form is needed for their prescription.
- Item not mentioned within that specific group.